With the analysis among 2,214 patents, we discovered top 456 key players by total patent application. GlaxoSmithKline Biologicals SA, Merck & Co., Inc., PreTect AS are dominant in this area. They take 9.44% of the total patent filing.
GlaxoSmithKline Biologicals SA
New Jersey, United States
Patent: 67
Buskerud, Norway
Patent: 62
Xiamen Innovax Biotech Co. Ltd.
Fujian Sheng, China
Patent: 49
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 45
California, United States
Patent: 42
German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)
Boehringer Ingelheim (Canada) Ltd.
Ontario, Canada
Patent: 23
New Jersey, United States
Patent: 23
Roche Molecular Systems, Inc.
California, United States
Patent: 22
With the analysis among 54 patents, we discovered top 13 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Agenovir Corp., Abviris Deutschland GmbH are active in this area.
Institut National de la Santé et de la Recherche Médicale
California, United States
Patent: 7
Thüringen, Germany
Patent: 4
Galvanize Therapeutics, Inc.
California, United States
Patent: 3
California, United States
Patent: 3
California, United States
Patent: 3
New York, United States
Patent: 2
Wuhan Huada Gino Biotechnology Co. Ltd.
Hubei Sheng, China
Patent: 2
Gyeonggi-do, South Korea
Patent: 2
Guangzhou HEAS BioTech Co., Ltd.
Guangdong Sheng, China
Patent: 2
With the analysis among related 683 patents applied in the last 5 years. We discover 284 most active companies in this area. The fast-growing Merck Sharp & Dohme LLC, Shenzhou Cell Engineering Co Ltd., Regeneron Pharmaceuticals, Inc. take 7.47% of patent filing during this period.
New Jersey, United States
Patent: 19
Shenzhou Cell Engineering Co Ltd.
Beijing Shi, China
Patent: 17
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 15
Inovio Pharmaceuticals, Inc.
Pennsylvania, United States
Patent: 15
Clackmannanshire, United Kingdom
Patent: 11
Washington, United States
Patent: 11
New Jersey, United States
Patent: 11
With the analysis among related 683 patents in last 5 years, we discover 221 new entrants. Shenzhou Cell Engineering Co Ltd., Regeneron Pharmaceuticals, Inc., SELO MEDICAL GmbH are the most active new entrants in this area.
Shenzhou Cell Engineering Co Ltd.
Beijing Shi, China
Patent: 17
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 15
Washington, United States
Patent: 11
New Jersey, United States
Patent: 11
Hangzhou Nuohui Health Technology Co. Ltd.
Zhejiang Sheng, China
Patent: 10
National Institute of Biomedical Innovation
Massachusetts, United States
Patent: 7
Zhenjiang Jieshengrui Technology Co., Ltd.
Jiangsu Sheng, China
Patent: 6
With the analysis among 675 patents, we discovered top 99 universities and scientific research institutions by total patent application. Xiamen University, The Johns Hopkins University, University of Cape Town are dominant in this area. They take 22.96% of the total patent filing.
Fujian Sheng, China
Patent: 59
The Johns Hopkins University
New York, United States
Patent: 28
Baylor College of Medicine
Texas, United States
Patent: 20
The University of Queensland
Queensland, Australia
Patent: 12
Université Libre de Bruxelles
Brussels Hoofdstedelijk Gewest, Belgium
Patent: 11
President & Fellows of Harvard College
Massachusetts, United States
Patent: 8
Institute of Basic Medical Sciences
Beijing Shi, China
Patent: 8